Form 4: DXCM EVP Stern Gains Shares from PSU Vesting

Dexcom's EVP, Chief HR Officer Sadie Stern acquired 7,123 shares of common stock through the vesting of performance-based restricted stock units, while 2,656 shares were withheld for tax obligations.

Summary

• Sadie Stern, Executive Vice President and Chief HR Officer of Dexcom Inc. (DXCM), acquired 7,123 shares of common stock.
• The acquisition resulted from the vesting of performance-based restricted stock units (PSUs) granted on March 8, 2023, due to the achievement of performance conditions.
• Concurrently, 2,656 shares were disposed of by the Issuer to cover tax withholding and remittance obligations related to the net settlement of these PSUs, at a price of $73.36 per share.
• Following these transactions, Sadie Stern beneficially owns 109,690 shares of Dexcom common stock.
• This beneficial ownership includes 74,450 unvested restricted stock units with various vesting schedules extending through March 8, 2028.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event. The vesting of PSUs indicates that performance conditions were met, and the executive's increased ownership aligns her interests with shareholders, which is generally favorable.

Positives

• Sadie Stern, a key executive, received 7,123 shares of common stock through the vesting of performance-based restricted stock units, indicating the achievement of company performance conditions.
• The vesting of PSUs aligns the executive's interests with those of shareholders, as her compensation is tied to company performance.

Future Outlook

Sadie Stern holds 74,450 unvested restricted stock units, which are scheduled to vest through various dates, with the latest vesting period concluding on March 8, 2028. This indicates a continued long-term incentive structure for the executive.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as the vesting of performance-based equity awards and subsequent tax withholdings, are common in the medical device and healthcare technology sectors. These events reflect standard executive compensation practices designed to align management incentives with long-term shareholder value creation, consistent with industry norms for companies like Dexcom.

Stakeholder Impact

• Shareholders: The vesting of PSUs results in a slight increase in outstanding shares, but it is a planned component of executive compensation and aligns management incentives with company performance.
• Employees: Reflects the company's compensation structure for executives, potentially setting a precedent or demonstrating the effectiveness of performance-based incentives.

Next Steps

• Continued vesting of 74,450 unvested restricted stock units held by Sadie Stern, with schedules extending through March 8, 2028.

Key Dates

Keywords

Dexcom, DXCM, Sadie Stern, Insider Transaction, Form 4, Performance Stock Units, PSU Vesting, Restricted Stock Units, Executive Compensation, Stock Ownership